An algorithm that combines machine learning ensemble modeling and network analysis to predict self-tolerant tumor-associated antigens for anti-cancer immunotherapy
Vera Gonzalez, J.; Eberhardt, M.; Lischer, C.; Weich, A.
Show abstract
Tumor-associated antigens (TAAs) and their derived peptides constitute the chance to design off-the-shelf mainline or adjuvant anti-cancer immunotherapies for a broad array of patients. Here, we present a computational pipeline that selects and ranks candidate antigens in a multi-pronged approach and applied it to the case of uveal melanoma. In addition to antigen expression in the tumor target and in healthy tissues, we incorporated a network analysis-derived antigen indispensability index motivated by computational modeling results, and candidate immunogenicity predictions from a machine learning ensemble model on peptide physicochemical characteristics.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The immunogenic potential of recurrent cancer drug resistance mutations: an in silico study 96%
- A systematic, unbiased mapping of CD8+ and CD4+ T cell epitopes in Yellow Fever vaccinees 94%
- Influence of HLA class II polymorphism on predicted cellular immunity against SARS-CoV-2 at the population and individual level 94%
Similar papers in this journal
- Beyond Sequence Similarity: ML-Powered Identification of pHLA Off-Targets for TCR-Mimic Antibodies Using High Throughput Binding Kinetics 96%
- BioPhi: A platform for antibody design, humanization and humanness evaluation based on natural antibody repertoires and deep learning 95%
- In silico proof of principle of machine learning-based antibody design at unconstrained scale 93%
Similar papers in this journal
- NeoPrecis: Enhancing Immunotherapy Response Prediction through Integration of Qualified Immunogenicity and Clonality-Aware Neoantigen Landscapes 94%
- scifAI: Explainable machine learning for profiling the immunological synapse and functional characterization of therapeutic antibodies 93%
- Deep learning predictions of TCR-epitope interactions reveal epitope-specific chains in dual alpha T cells 93%
Similar papers in this journal
- DeepImmuno: Deep learning-empowered prediction and generation of immunogenic peptides for T cell immunity 97%
- ImmuneMirror: a Machine Learning-based Integrative Pipeline and Web Server for Neoantigen Prediction 93%
- ACE Configurator for ELISpot (ACE): Optimizing Combinatorial Design of Pooled ELISpot Assays with an Epitope Similarity Model 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.